12:00 AM
 | 
Mar 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Threshold, Siemens deal

Threshold acquired worldwide rights to develop and commercialize PET imaging tracer 18F-HX4 (flortanidazole) from Siemens' Siemens Healthcare unit. Threshold initially plans to develop 18F-HX4 to...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >